LEXINGTON, Mass.--(BUSINESS WIRE)--Synta Pharmaceuticals Corp. (NASDAQ: SNTA) announced today that a poster highlighting preclinical results from its Hsp90 inhibitor Drug Conjugate (HDC) platform is being presented at the 26th EORTC-NCI-AACR Symposium in Barcelona.
Help employers find you! Check out all the jobs and post your resume.
